Risk Factors for Renal Cell Carcinoma in a Japanese Population

  • Washio, Masakazu ;
  • Mori, Mitsuru ;
  • Mikami, Kazuya ;
  • Miki, Tsuneharu ;
  • Watanabe, Yoshiyuki ;
  • Nakao, Masahiro ;
  • Kubo, Tatsuhiko ;
  • Suzuki, Koji ;
  • Ozasa, Kotaro ;
  • Wakai, Kenji ;
  • Tamakoshi, Akiko
  • Published : 2014.11.28


The incidence of renal cell carcinoma (RCC) is high in Western and Northern Europe and North America, and low in Asia. Although the incidence of RCC in Japan is lower than the rates in the other industrialized countries, there is no doubt that it is increasing. In this paper, we would like to introduce the summary of findings of JACC study, which evaluate the risk factors for RCC in a Japanese population. JACC study suggests nine risk factors (i.e., smoking, obesity, low physical activity, hypertension, diabetes mellitus, kidney diseases, beef, fondness for fatty food and black tea) and one preventive factor (i.e., starchy roots such as taro, sweet potato and potato) in a Japanese population. In Japan, however, drinking black tea may be a surrogate for westernized dietary habits while eating starchy roots may be a surrogate for traditional Japanese dietary habits. Further studies may be needed to evaluate risk factors for RCC because the number of cases is small in our studies.


Renal cell carcinoma;risk factor;Japan


  1. Lowrance WT, Ordonez J, Udaltsova N, et al. (2014). CKD and the risk of incident cancer. J Am Soc Nephrol, published online, May 29, 2004, doi: 10.1681 /ASN.2013060604.
  2. Mahabir S, Leitzmann MF, Pietien P, et al (2004). Physical activity and renal cell cancer risk in a cohort of male smokers. Int J Cancer, 108, 600-5.
  3. Maratos-Flier E, Flier JS (2004). Obesity. In: Khan CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ (eds). Joslin's Diabetes Mellitus, 14th edn. Williams & Wilkins, Baltimore, 533-45.
  4. Marumo K, Satomi Y, Miyao N, et al (2001). The prevalence of renal cell carcinoma: a naion-wide survey in Japan in 1997. Int J Urology, 8, 359-65.
  5. Marumo K, Kanayama H, Miyao N, et al (2007). Prevalence of renal cell carcinoma: a naion-wide survey in Japan in 2002. Int J Urology, 14, 479-82.
  6. McLaughlin JK, Blot WJ, Devesa SS, et al (1996). Renal Cancer. In: Schottenfeld D, Fraumeni JF, Jr (eds). Cancer Epidemiology and Prevention. Oxford University Press, New York, 1142-55.
  7. Lindblad P, Chow WH, Chan J, et al (1999). The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia, 42, 107-12.
  8. Lindblad P, Adami HO (2002). Kidney cancer. In: Adami HO, Hunter D, Trichopoulos D (eds). Textbook of Cancer Epidemiology. Oxford University Press, New York, 467-85.
  9. McLaughlin JK, Lipworth L, Tarone RE, et al (2006). Renal Cancer. In: Schottenfeld D, Fraumeni JF, Jr (eds). Cancer Epidemiology and Prevention, 3rd edn. Oxford University Press, New York, 1087-1100.
  10. Menezes RJ, Tomlinson G, Kreiger N (2003). Physical activity and risk of renal cell carcinoma. Int J Cancer, 107, 642-6.
  11. Mellemgaard A, Niwa S, Mehl ES, et al (1994). Risk factors for renal cell carcinoma in Denmark: role of medication and medical history. Int J Epidemiol, 23, 923-30.
  12. Mucci LA, Dickman PW, Steineck G, et al (2003). Dietary acrylamide and cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden. Br J Cancer, 88, 84-9.
  13. Ohno Y, Tamakoshi A, the JACC Study Group (2001). "Japan Collaborative Cohort Study for the Evaluation of Cancer Risk sponsored by Monbusho (JACC Study). J Epidemiol, 11, 144-50.
  14. Pandey M, Shukla VK (2002). Diet and gallbladder cancer: a case control study. Eur J Cancer Prev, 11, 365-8.
  15. Parkin DM, Whelan SL, Ferlay J, et al (2002). Cancer Incidence in Five Continents. Vol. 8. International Agency for Research on Cancer, Lyon.
  16. Sawada N, Inoue M, Sasazuki S, et al (2010). Body mass index and subsequent risk of kidney cancer: a prospective cohort study in Japan. Ann Epidemiol, 20, 466-72.
  17. Tamakoshi A, Ozasa K, Fujino Y, et al (2013). Cohort profile of the Japan Collaborative Cohort Study at final follow-up. J Epidemiology, 33, 227-32.
  18. Thun MJ, Henley SJ. Tobacco. In: Schottenfeld D, Fraumeni JF, Jr (eds). Cancer Epidemiology and Prevention, 3rd edn. Oxford University Press, New York, 217-242.
  19. Toma H (2003). Epidemiology of kidney cancer. In: Toma H, Nakazawa H (eds). All About Kidney Cancer: Basic Medicine and Clinical Practice. Medical View, Tokyo, 2-10. (in Japanese).
  20. Washio M, Mori M, Sakauchi F, et al (2005). Risk factors for kidney cancer in a Japanese population: findings from the JACC study. J Epidemiol, 15, 203-11.
  21. Washio M, Mori M, Khan MMH, et al (2007). Diabetes mellitus and kidney cancer risk: the results of Japan collaborative cohort study for evaluation of cancer risk (JACC study). Int J Urology, 14, 393-7.
  22. Washio M, Mori M, Sakauchi F, et al (2008). Hypertension and other risk factors for the development of kidney cancer (renal cell carcinoma) in a Japanese population: findings from the JACC study. Int Med J, 15, 343-347.
  23. Washio M, Mori M, Mikami K, et al (2013). Cigarette smoking and other risk factors for kidney cancer death in a Japanese population: Japan collaborative cohort Study for Evaluation of Cancer Risk (JACC study). Asian Pac J Cancer Prev, 14, 6523-8.
  24. WHO (2003). World Cancer Report. In: Stewart BW, Kleihues P (eds). International Agency for Research on Cancer Press, Lyon.
  25. Wideroff L, Gridley G, Mellemkjaer L, et al (1997). Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst, 89, 1360-5.
  26. Yu MC, Mack TM, Hanisch R, et al (1986). Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J Natl Cancer Inst, 77, 351-6.
  27. Yuan JM, Castellao JE, Gago-Dominguez M, et al (1998). Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer, 77, 1508-13.
  28. Bellocco R, Pasquali E, Rota M, et al (2012). Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis. Ann Oncology, 23, 2235-44.
  29. Brosman SA (1989). Tumors of the kidney and urinary tract. In: Massry SG, Glassock RJ (eds). Textbook of Nephrology, 2nd edn. Williams and Wilkins, Baltimore, 942-61.
  30. Cerhan JR, Wasslace RB, Folsom AR, et al (1997). Medical history risk factors for non-Hodgkin's lymphoma in older women. J Natl Cancer Inst, 89, 314-8.
  31. Chow WH, Gridley G, McLaughlin JK, et al (1994). Protein intake and risk of renal cell cancer. J Natl Cancer Inst, 86, 1131-9.
  32. Chow WH, Gridley G, Fraumeni JF, et al (2000). Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med, 343, 1305-11.
  33. Davies MJ, Baer DJ, Judd JT, et al (2002). Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA, 287, 2559-62.
  34. Gajalakshmi CK, Jha P, Ranson K, et al. (2000). Global patterns of smoking and smoking-attributable mortality. In 'Tobacco control in developing countries' Eds Jha P, Chalouplca F. Oxford University Press: New York, 11-39.
  35. Handa K, Kreiger N (2002). Diet patterns and the risk of renal cell carcinoma. Public Health Nutrition, 5, 757-67.
  36. Hirata Y (1991). Pathogenesis. In: Treatment for Diabetes Mellitus. Bunkodo, Tokyo, 53-141 (in Japanese).
  37. Japanese Ministry of Health, Labour and Welfare (2013). Trend of National Health 2013/2014. Health, Labour and Welfare Statistical Association, Tokyo (in Japanese).
  38. Kaplan NM (2002). Primary hypertension: pathogensesis. In: Kaplan NM (eds). Kaplan's Clinical Hypertension 8th edn. Lippincott Williams & Wilkins, Philadelphia, 56-135.
  39. Kim HW, Murakami A, Nakamura Y, et al (2002). Screening of edible Japanese plants for suppressive effects on phorbol ester-induced superoxide generation in differentiated HL-60 cells and AS52 cells. Cancer Letters, 176, 7-16.
  40. Kim OK, Murakami A, Nakamura Y, et al (1998). Screening of edible Japanese plants for nitric oxide generation inhibitory activities in RAW 264.7 cells. Cancer letter, 125, 199-207.
  41. Kojima Y, Takahara S, Miyake S, et al (2006). Renal cell carcinoma in dialysis patients: a single center experience. Int J Urol, 13, 1045-8.
  42. Landsberg L(2005). Insulin-resistance and metabolic syndrome. Diabetologia, 48, 1244-6.
  43. Levine TB, Levine AB (2006). Comorbidities of the metabolic syndrome. In: Metabolic syndrome and cardiovascular disease. Saunder, Philadelphia, 263-79.
  44. Lew JQ, Chow WH, Hollenbeck AR, et al (2011). Alcohol consumption and risk of renal cell cancer: the NIH-AARP diet and health study. Br J Cancer, 104, 537-41.

Cited by

  1. P53 and MDM2 Over-expression and Five-year Survival of Kidney Cancer Patients Undergoing Radical Nephrectomy - Iranian Experience vol.16, pp.12, 2015,
  2. Epidemiology and Trends in Incidence of Kidney Cancer in Iran vol.16, pp.14, 2015,
  3. Mutagenicity Assessment of Drinking Water in Combination with Flavored Black Tea Bags: a Cross Sectional Study in Tehran vol.16, pp.17, 2015,
  4. Incremental Expression of 14-3-3 Protein Beta/Alpha in Urine Correlates with Advanced Stage and Poor Survival in Patients with Clear Cell Renal Cell Carcinoma vol.17, pp.3, 2016,
  5. Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concern vol.6, pp.1, 2016,
  6. IL-8 induces the epithelial-mesenchymal transition of renal cell carcinoma cells through the activation of AKT signaling vol.12, pp.3, 2016,